Company intelligence / Profile preview
Xequel Bio
Fort Worth, Texas, USAxequel.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Xequel Bio has developed a proprietary peptide technology platform based on the alpha‑Connexin carboxyl‑Terminal peptide family. Its lead product, Granexin® Gel, has advanced through multiple clinical trials targeting wound healing and inflammatory skin conditions. The company’s pipeline includes topical formulations for chronic wounds as well as ophthalmic solutions. Clinical results have shown promise in modulating excessive inflammation and improving tissue regeneration outcomes.[2][3]
- Therapeutic areas
- PulmonologyOphthalmologyImmunologyDermatologyNeurology
- Modalities
- Synthetic peptides (notably aCT1 peptide)Recombinant polypeptides[4]Interleukins[4]
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Exclusive license from Medical University of South Carolina; no major pharma partnerships disclosed.[2]
Beyond the preview
Go deeper on Xequel Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xequel Bio.